Skip to main content

Table 1 Demographic and disease-related variables in 163 female patients with systemic lupus erythematosus

From: Role of resistin as a marker of inflammation in systemic lupus erythematosus

Demographic variables Value
   Patient age, years 47 (20 to 82)
   Weight, kg 66 (42 to 99)
   Height, cm 166 (145 to 182)
   Body mass index, kg/m2 24.2 (17.2 to 37.2)
   Menopausal status  
Premenopausal, n (%) 72 (44)
Disease variables  
   Disease duration, years 11 (1 to 41)
   SLEDAI-2K 5 (0 to 31)
   SLICC/ACR Damage Index 2 (0 to 11)
   Kidney affection ever by SLE, n (%) 40 (25)
   S-creatinine, μmol/L 87 (49 to 291)
   Glomerular filtration rate, mL/minute 74 (22 to 172)
   Proteinuria, >3.5 g/24 hours, n (%) 9 (6)
   End-stage kidney disease, n (%) 1 (0.6)
   Hemoglobin, g/L 131 (75 to 158)
   Erythrocyte sedimentation rate, mm/hour 25 (2 to 125)
   C-reactive protein, mg/L 5 (3 to 100)
   Cholesterol, mmol/L 5.4 (2.4 to 9.3)
   High-density lipoprotein, mmol/L 1.6 (0.5 to 2.8)
   Low-density lipoprotein, mmol/L 3.1 (<0.1 to 6.3)
   Triglycerides, mmol/L 1.2 (0.3 to 6.0)
   Albumin, g/L 40 (11 to 53)
   IgG, g/L 13.5 (5 to 28)
   IgA, g/L 2.5 (0.07 to 11)
   IgM, g/L 1.0 (0.05 to 4.6)
   C3, g/L 0.93 (0.28 to 1.68)
   C4, g/L 0.14 (0.02 to 0.28)
   Tumor necrosis factor-alpha, pg/mL 2.16 (0.40 to 36.96)
   Interleukin-1β, pg/mL 0.47 (0.0 to 9.65)
   Interleukin-6, pg/mL 9.67 (2.81 to 119.0)
   sIL-6R, ng/mL 48.87 (11.56 to 107.15)
   Glucocortocosteroid user, n (%) 85 (52)
Glucocorticosteroid dose, mg 5 (2.5 to 35)
   BMD lumbal spine, g/cm2, mean (SD) 1.12 (0.18)
   BMD total hip, g/cm2, mean (SD) 0.92 (0.15)
   BMD femur neck, g/cm2, mean (SD) 0.89 (0.15)
   BMD radius total, g/cm2, mean (SD) 0.50 (0.08)
   Number of vertebral fractures per patient 0 (0 to 11)
   ICTP, μg/L 3.59 (0.9 to 16.38)
   PINP, μg/L 43.0 (9.1 to 177.94)
  1. Values are presented as median (and range) unless indicated otherwise. BMD, bone mineral density; ICTP, C-terminal telopeptide of type I collagen; Ig, immunoglobulin; PINP, N-terminal propeptide of type I procollagen; SD, standard deviation; sIL-6R, soluble interleukin-6 receptor; SLE, systemic lupus erythematosus; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; SLICC/ACR, Systemic Lupus International Collaborative Clinics/American College of Rheumatology.